BMC Cancer 22 (1): 47, 2022.[PUBMED Abstract] Brooks GA, Tapp S, Daly AT, et al.: Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer.
Clin Colorectal Cancer 21 (3): e189-e195, 2022.[PUBMED Abstract] Baker SD, Bates SE, Brooks GA, et al.: DPYD Testing: Time to Put Patient Safety First.
J Clin Oncol 41 (15): 2701-2705, 2023.[PUBMED Abstract] Wolff AC, Blackford AL, Visvanathan K, et al.: Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.
J Clin Oncol 33 (4): 340-8, 2015.[PUBMED Abstract] Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al.: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.